Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop.

Guidelines for testing slow acting drugs in osteoarthritis
Lequesne
J Rheumatol, (Suppl 41) 1994
Title not supplied
AUTHOR UNKNOWN
1995
Title not supplied
Furst
1995
Recommendations for the registration of drugs used in the treatment of osteoarthritis
AUTHOR UNKNOWN
Ann Rheum Dis 1996
Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis: consensus development at OMERACT III
Bellamy
J Rheumatol 1996
Degenerative joint disease.
Altman RD, Hochberg MC
Clin Rheum Dis, (3):681-693 1983
MED: 6360521
Clinical trials. A guide to understanding methodology and interpreting results.
Ratain JS, Hochberg MC
Arthritis Rheum, (1):131-139 1990
MED: 2405862
FDA Document #77-3040. General considerations for the clinical evaluation of drugs, CDER Executive secretarial staff, HFD-8, FDA (Center for Drug Evaluation and Research, 5400 Fisher's lane, Rockville, MD 20857.
FDA Document: Guidelines for industry. The extent of population exposure to assess clinical safety: for drugs intended for long-term treatment of non-lifethreatening conditions, ICH-EIA, March 1995; Federal Register March 1, 1995 (60FR11270).
Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.
Altman R, Asch E, Bloch D, Bole G, Borenstein D, Brandt K, Christy W, Cooke TD, Greenwald R, Hochberg M
Arthritis Rheum, (8):1039-1049 1986
MED: 3741515

Show 10 more references (10 of 119)

Citations & impact

Impact metrics

318

Citations

Jump to Citations

Citations of article over time

Alternative metrics

Altmetric item for https://www.altmetric.com/details/2789052

Altmetric
Discover the attention surrounding your research
https://www.altmetric.com/details/2789052

Article citations

Efficacy of lower limb strengthening exercises based on different muscle contraction characteristics for knee osteoarthritis: a systematic review and network meta-analysis.
Ding X, Yang Y, Xing Y, Jia Q, Liu Q, Zhang J
Front Med (Lausanne), 11:1442683, 25 Sep 2024
Cited by: 0 articles | PMID: 39386751 | PMCID: PMC11461219
Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: Systematic review and meta-analysis of randomized controlled trials.
Tabet CG, Pacheco RL, Martimbianco ALC, Riera R, Hernandez AJ, Bueno DF, Fernandes TL
J Orthop Translat, 48:176-189, 26 Aug 2024
Cited by: 0 articles | PMID: 39360004 | PMCID: PMC11445595
Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Potential Role of Probiotics in the Management of Osteoarthritis Pain: Current Status and Future Prospects.
Rahman SO, Bariguian F, Mobasheri A
Curr Rheumatol Rep, 25(12):307-326, 01 Sep 2023
Cited by: 5 articles | PMID: 37656392 | PMCID: PMC10754743
Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Osteoarthritis.
Buchanan WW, Kean CA, Kean WF, Rainsford KD
Inflammopharmacology, 32(1):13-22, 17 May 2023
Cited by: 1 article | PMID: 37195499
Metformin attenuates symptoms of osteoarthritis: role of genetic diversity of Bcl2 and CXCL16 in OA.
Alimoradi N, Tahami M, Firouzabadi N, Haem E, Ramezani A
Arthritis Res Ther, 25(1):35, 07 Mar 2023
Cited by: 3 articles | PMID: 36879307 | PMCID: PMC9990216
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

Go to all (318) article citations

Search life-sciences literature (45,103,589 articles, preprints and more)

Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop.

Affiliations

ORCIDs linked to this article

Abstract

Full text links

References

Guidelines for testing slow acting drugs in osteoarthritis

Title not supplied

Title not supplied

Recommendations for the registration of drugs used in the treatment of osteoarthritis

Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis: consensus development at OMERACT III

Degenerative joint disease.

Clinical trials. A guide to understanding methodology and interpreting results.

FDA Document #77-3040. General considerations for the clinical evaluation of drugs, CDER Executive secretarial staff, HFD-8, FDA (Center for Drug Evaluation and Research, 5400 Fisher's lane, Rockville, MD 20857.

FDA Document: Guidelines for industry. The extent of population exposure to assess clinical safety: for drugs intended for long-term treatment of non-lifethreatening conditions, ICH-EIA, March 1995; Federal Register March 1, 1995 (60FR11270).

Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association.

Citations & impact

Impact metrics

Citations of article over time

Alternative metrics

Article citations

Efficacy of lower limb strengthening exercises based on different muscle contraction characteristics for knee osteoarthritis: a systematic review and network meta-analysis.

Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: Systematic review and meta-analysis of randomized controlled trials.

The Potential Role of Probiotics in the Management of Osteoarthritis Pain: Current Status and Future Prospects.

Osteoarthritis.

Metformin attenuates symptoms of osteoarthritis: role of genetic diversity of Bcl2 and CXCL16 in OA.

Similar Articles

Design and conduct of clinical trials in patients with osteoarthritis of the hand: recommendations from a task force of the Osteoarthritis Research Society International.

Six Weeks of Prednisolone Reduced Hand Osteoarthritis Pain.

Design and conduct of clinical trials in osteoarthritis: preliminary recommendations from a task force of the Osteoarthritis Research Society.

[Effect of hyaluronic acid is examined in clinical studies].

Partnerships & funding

Search life-sciences literature (45,103,589 articles, preprints and more)

Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop.

Author information

Affiliations

ORCIDs linked to this article

Abstract

Full text links

References

Guidelines for testing slow acting drugs in osteoarthritis

Title not supplied

Title not supplied

Recommendations for the registration of drugs used in the treatment of osteoarthritis

Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip, and hand osteoarthritis: consensus development at OMERACT III

FDA Document #77-3040. General considerations for the clinical evaluation of drugs, CDER Executive secretarial staff, HFD-8, FDA (Center for Drug Evaluation and Research, 5400 Fisher's lane, Rockville, MD 20857.

FDA Document: Guidelines for industry. The extent of population exposure to assess clinical safety: for drugs intended for long-term treatment of non-lifethreatening conditions, ICH-EIA, March 1995; Federal Register March 1, 1995 (60FR11270).

Citations & impact

Impact metrics

Citations of article over time

Alternative metrics

Article citations

Similar Articles

Partnerships & funding